These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3098666)

  • 1. Characterization of the molecular forms of fibronectin in fulminant hepatic failure.
    Almasio PL; Hughes RD; Williams R
    Hepatology; 1986; 6(6):1340-5. PubMed ID: 3098666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective study of plasma fibronectin in fulminant hepatitis: association with infection and mortality.
    Acharya SK; Dasarathy S; Irshad M
    J Hepatol; 1995 Jul; 23(1):8-13. PubMed ID: 8530814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibronectin and Kupffer cell function in fulminant hepatic failure.
    Imawari M; Hughes RD; Gove CD; Williams R
    Dig Dis Sci; 1985 Nov; 30(11):1028-33. PubMed ID: 4053913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibronectin replacement in patients with fulminant hepatic failure.
    Hughes RD; Imawari M; Bihari D; Almasio PL; Langley PG; Williams R
    Eur J Clin Invest; 1986 Oct; 16(5):352-6. PubMed ID: 3100301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma levels and hepatic mRNA expression of transforming growth factor-beta1 in patients with fulminant hepatic failure.
    Miwa Y; Harrison PM; Farzaneh F; Langley PG; Williams R; Hughes RD
    J Hepatol; 1997 Nov; 27(5):780-8. PubMed ID: 9382963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibronectin in acute and subacute hepatic failure.
    Anand AC; Irshad M; Acharya SK; Gandhi BM; Joshi YK; Tandon BN
    J Clin Gastroenterol; 1989 Jun; 11(3):314-9. PubMed ID: 2754218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extent of the acute phase response in fulminant hepatic failure.
    Izumi S; Hughes RD; Langley PG; Pernambuco JR; Williams R
    Gut; 1994 Jul; 35(7):982-6. PubMed ID: 8063228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibronectin in fulminant hepatic failure.
    Gonzalez-Calvin J; Scully MF; Sanger Y; Fok J; Kakkar VV; Hughes RD; Gimson AE; Williams R
    Br Med J (Clin Res Ed); 1982 Oct; 285(6350):1231-2. PubMed ID: 6812819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma hepatocyte growth factor and biliprotein levels and outcome in fulminant hepatic failure.
    Hughes RD; Zhang L; Tsubouchi H; Daikuhara Y; Williams R
    J Hepatol; 1994 Jan; 20(1):106-11. PubMed ID: 8201209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human hepatocyte growth factor in blood of patients with fulminant hepatic failure. Basic aspects.
    Gohda E; Tsubouchi H; Nakayama H; Hirono S; Arakaki N; Yamamoto I; Hashimoto S; Daikuhara Y
    Dig Dis Sci; 1991 Jun; 36(6):785-90. PubMed ID: 1827762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of human hepatocyte growth factor in blood from patients with fulminant hepatic failure.
    Tsubouchi H; Hirono S; Gohda E; Nakayama H; Takahashi K; Sakiyama O; Miyazaki H; Sugihara J; Tomita E; Muto Y
    Hepatology; 1989 Jun; 9(6):875-81. PubMed ID: 2523850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombin-antithrombin III complex in fulminant hepatic failure: evidence for disseminated intravascular coagulation and relationship to outcome.
    Langley PG; Forbes A; Hughes RD; Williams R
    Eur J Clin Invest; 1990 Dec; 20(6):627-31. PubMed ID: 2127751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The significance of structural glycoproteins, demonstrated by the example of the fibronectins. Biochemical principles and clinical use].
    Pott G; Zündorf P; Gerlach U; Voss B; Rauterberg J
    Z Gastroenterol; 1982 Nov; 20(11):649-58. PubMed ID: 6758388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of fibronectin and complement in immunopathogenesis of acute and subacute hepatic failure.
    Irshad M; Acharya SK; Joshi YK; Tandon BN
    J Gastroenterol Hepatol; 1994; 9(4):355-60. PubMed ID: 7948818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different molecular forms of fibronectin in rheumatoid synovial fluid.
    Clemmensen I; Andersen RB
    Arthritis Rheum; 1982 Jan; 25(1):25-31. PubMed ID: 7066034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Our experience with fulminant hepatic failure in Turkish children: etiology and outcome.
    Aydoğdu S; Ozgenç F; Yurtsever S; Akman SA; Tokat Y; Yağci RV
    J Trop Pediatr; 2003 Dec; 49(6):367-70. PubMed ID: 14725414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zinc abnormalities in fulminant hepatic failure.
    Canalese J; Sewell RB; Poston L; Williams R
    Aust N Z J Med; 1985 Feb; 15(1):7-9. PubMed ID: 3859271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure.
    Harrison PM; Wendon JA; Gimson AE; Alexander GJ; Williams R
    N Engl J Med; 1991 Jun; 324(26):1852-7. PubMed ID: 1904133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digoxin-like immunoreactive substances in severe acute liver disease due to viral hepatitis and paracetamol overdose.
    Yang SS; Hughes RD; Williams R
    Hepatology; 1988; 8(1):93-7. PubMed ID: 2828215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human atrial natriuretic factor and renin-aldosterone in paracetamol induced fulminant hepatic failure.
    Panos MZ; Anderson JV; Forbes A; Payne N; Slater JD; Rees L; Williams R
    Gut; 1991 Jan; 32(1):85-9. PubMed ID: 1825077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.